Avantor, Inc. (AVTR) is held by 5 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 5 funds adding and 1 fund trimming or exiting versus the previous quarter. Latest close $15.37 as of Nov 18, 2026.
Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: none in the last 90 days · Congress to Nov 16, 2026.
Greenhaven Associates · Southeastern Asset Management · First Pacific Advisors — 5 tracked funds hold AVTR. See all holders.
No insider open-market activity or Congress trades reported for this stock in the recent window. Insider trading · Politician trading.
BAXTER INTERNATIONAL INC (BAX) · PayPal Holdings, Inc. (PYPL) · Aon plc (AON) · WELLS FARGO & COMPANY/MN (WFC) · COMCAST CORP (CMCSA) — stocks the same funds also hold. See all related stocks.
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Greenhaven Associates | 2.82% | 24,637,310 | ADDED (+9.0%) Q3 filed Oct 26 |
| Southeastern Asset Management | 2.44% | 4,725,478 | ADDED (+34.2%) Q3 filed Nov 16 |
| First Pacific Advisors | 1.00% | 8,190,740 | ADDED (+1.3%) Q3 filed Nov 12 |
| Dodge & Cox Funds | 0.62% | 120,020,974 | ADDED (+0.3%) Q3 filed Nov 13 |
| Yacktman Asset Management | 0.58% | 4,770,000 | ADDED (+0.5%) Q3 filed Nov 2 |
| Maverick Capital | — | — | EXITED |
Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.
Price change since quarter-end: +51.6% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.
| Institutions holding | 457 of 8,857 filers |
| Long-only filers among them | 455 |
| Change vs 2026 Q1 | +36 net · 440 entered · 404 exited |
| Shares reported, all filers | 698,433,499 |
| Reported value, all filers | $6.8B |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
| Exchange | NYSE |
| Industry | Laboratory Analytical Instruments (SIC 3826) |
| Revenue · FY2025 | $6.6B |
| Net income · FY2025 | $-530.2M |
| Total assets · FY2025 | $11.8B |
| Shares outstanding | 677,615,769 |
| Market cap (at latest close) | $10.4B |
Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Oct 23, 2026.
| Shares short · Oct 15, 2026 | 34,645,265 |
| Share of shares outstanding | 5.11% |
| Days to cover | 4.58 |
Shares short at recent settlements — Jul 31, 2026: 53.2M · Aug 14, 2026: 52.2M · Aug 31, 2026: 50.2M · Sep 15, 2026: 51.4M · Sep 30, 2026: 39.3M · Oct 15, 2026: 34.6M.
Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Oct 23, 2026.
| Shares failed to deliver · Oct 14, 2026 | 0 |
| Share of shares outstanding | 0.00% |
| Fails as a share of short interest · Oct 15, 2026 | 0.0% |
Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 16K · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 0.
Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Oct 23, 2026.
Data unavailable — no Form 4 transactions for this ticker were parsed in the last 90 days.
| Filed | Seller | Role | Shares to sell | Market value | Approx. sale date | Source |
|---|---|---|---|---|---|---|
| Nov 6, 2025 | Todd Edwards | officer | 29,131 | $732.9K | Nov 6, 2025 | SEC filing |
| Aug 5, 2025 | Eck Steven W | Officer | 3,476 | $39.6K | Aug 5, 2025 | SEC filing |
| Feb 27, 2025 | Bramwell James | Officer | 774 | $13.2K | Feb 27, 2025 | SEC filing |
| Feb 27, 2025 | Eck Steven W | Officer | 1,033 | $17.6K | Feb 27, 2025 | SEC filing |
| Feb 26, 2025 | Bramwell James | Officer | 3,758 | $65.9K | Feb 26, 2025 | SEC filing |
| Feb 26, 2025 | Eck Steven W | Officer | 4,907 | $86.0K | Feb 26, 2025 | SEC filing |
| Sep 5, 2024 | Eck Steven W | Officer | 3,525 | $88.3K | Sep 5, 2024 | SEC filing |
| Aug 26, 2024 | Wondrasch Michael | Officer | 17,000 | $434.2K | Aug 26, 2024 | SEC filing |
| Jul 31, 2024 | Couturier Christophe | Officer | 100 | $2.8K | Jul 31, 2024 | SEC filing |
| Jul 30, 2024 | Couturier Christophe | Officer | 10,000 | $270.1K | Jul 30, 2024 | SEC filing |
A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.
| Filed | Filer | Form | Shares | % owned | Event date | Source |
|---|---|---|---|---|---|---|
| Apr 29, 2026 | Vanguard Capital Management | SC 13G | 35,802,263 | 5.3% | Mar 31, 2026 | SEC filing |
| Mar 26, 2026 | The Vanguard Group | SC 13G/A | 0 | 0.0% | Mar 13, 2026 | SEC filing |
| Nov 14, 2025 | T. Rowe Price Investment Management, Inc. | SC 13G/A | 32,928,415 | 4.8% | Sep 30, 2025 | SEC filing |
| Oct 17, 2025 | BlackRock, Inc. | SC 13G/A | 59,049,575 | 8.7% | Sep 30, 2025 | SEC filing |
| Aug 14, 2025 | T. Rowe Price Investment Management, Inc. | SC 13G/A | 56,500,715 | 8.3% | Jun 30, 2025 | SEC filing |
| Aug 13, 2025 | Dodge & Cox | SC 13G/A | 117,433,484 | 17.2% | Jun 30, 2025 | SEC filing |
| Feb 14, 2025 | T. Rowe Price Investment Management, Inc. | SC 13G/A | 41,360,393 | 6.1% | Dec 31, 2024 | SEC filing |
| Feb 13, 2025 | Dodge & Cox | SC 13G/A | 99,145,770 | 14.6% | Dec 31, 2024 | SEC filing |
One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.
Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).
Industry: Laboratory Analytical Instruments (SIC 3826). No standing committee maps to this industry under the site’s jurisdiction rule — see Methodology.
Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.
Lobbying: no Lobbying Disclosure Act filings matched for this ticker (1999–2026).
Federal contracts: $24.7M in obligated amounts, fiscal years 2021–2026.
| Fiscal year | Obligated amount |
|---|---|
| FY2021 | $2.4M |
| FY2022 | $11.2M |
| FY2023 | $10.8M |
| FY2024 | $245.2K |
| FY2025 | $0 |
| FY2026 | $-1.3K |
Largest awards collected
| Award ID | Agency | Amount | Start |
|---|---|---|---|
| 75N98022F00053 | Department of Health and Human Services | $53.8K | Dec 22, 2021 |
| 36C24118F1634 | Department of Veterans Affairs | $15.4K | Sep 14, 2018 |
| HHSN27200014 | Department of Health and Human Services | $10.0K | Aug 25, 2017 |
| SPE2D622F37V7 | Department of Defense | $5.8K | Dec 9, 2021 |
| SPE2D622F38S4 | Department of Defense | $5.7K | Dec 9, 2021 |
Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.
Chart Signals
· Monthly Uptrend — Price above its 12-month moving average
· Top Relative Strength — Top 20% of the universe by 6-month return
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
· Insider BEST — appeared in 4 of the last 20 quarterly lists; latest 2026 Q1, ranked #23 of 50.
| 13F signal (2021 Q3 – 2026 Q1) | Events | Win rate | Avg return | SPY | Excess |
|---|---|---|---|---|---|
| Heavy accumulation — 3+ tracked funds increased together | 2 | 50.0% | +4.2% | +8.4% | -4.3% |
| Share count tripled (3x) | 2 | 50.0% | -6.5% | +4.3% | -10.7% |
Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.
Also held by the tracked funds that hold AVTR — ranked by lift, the co-holding pattern described in Methodology: BAXTER INTERNATIONAL INC (BAX) · PayPal Holdings, Inc. (PYPL) · Aon plc (AON) · WELLS FARGO & COMPANY/MN (WFC) · COMCAST CORP (CMCSA) · SCHWAB CHARLES CORP (SCHW).
| Filed | Items | Source |
|---|---|---|
| Nov 3, 2026 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers · 9.01 Financial Statements and Exhibits | SEC filing |
| Oct 28, 2026 | 2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits | SEC filing |
| Sep 21, 2026 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits | SEC filing |
Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.
BAXTER INTERNATIONAL INC (BAX) · Track Record: how the signals scored · Practice timing on AVTR
One email a week: the week’s new filings and research. Subscribe free
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.